Activist investor Jason Hope is a well-known entrepreneur and philanthropist. He holds great expertise in the field of anti-aging as well as longevity. Jason Hope believes that stem cells are the way to the future in both of these areas and may promote huge benefits in other areas of medicine too.
However, the business expert and angel investor stresses that there is still much research to be done to perfect these advancements in the health and wellness industry. Jason Hope has worked with the SENS Organization (Strategies for Engineered Negligible Senescence) intensely and states that at this point in stem cell research everything is still in the experimental stages.
Additionally, he believes that with further testing along with more research and development in the stem cell sector that several answers we have been looking for may be found. This includes the potential benefits of promoting better health, increased longevity, and overall slowing down the aging process through stem cell treatments. Jason Hope is one of the strongest investors in the field of anti aging and longevity research.
With the SENS Foundation Organization and activist investor Jason Hope’s contributions to them, research and development continually are looking for different ways to use stem cells for medical treatments. This, to help prevent the onset and occurrence of degenerative diseases instead of treating the disease as it progresses. Jason Hope states that a perfect example of this is the current research that is being done to prevent Parkinson’s Disease, which is now in its second stage of clinical trials.
Although it may seem that the research is taking a long time, Hope stresses the importance of doing this correctly as there are studies that must be done as well as the risks that may be involved in any type of medical research before these treatments can be made available for people. Jason Hope stresses the benefits of stem cells and that what they may be able to do for humans are endless and wholeheartedly believes that the best is yet to come.